FLUPHENAZINE DECANOATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Fluphenazine Decanoate, and when can generic versions of Fluphenazine Decanoate launch?
Fluphenazine Decanoate is a drug marketed by Endo Operations, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, MSN, Mylan Labs Ltd, and Teva Parenteral. and is included in nine NDAs.
The generic ingredient in FLUPHENAZINE DECANOATE is fluphenazine decanoate. There are nineteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the fluphenazine decanoate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Fluphenazine Decanoate
A generic version of FLUPHENAZINE DECANOATE was approved as fluphenazine decanoate by FRESENIUS KABI USA on July 14th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLUPHENAZINE DECANOATE?
- What are the global sales for FLUPHENAZINE DECANOATE?
- What is Average Wholesale Price for FLUPHENAZINE DECANOATE?
Summary for FLUPHENAZINE DECANOATE
| US Patents: | 0 |
| Applicants: | 9 |
| NDAs: | 9 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 57 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,965 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for FLUPHENAZINE DECANOATE |
| DailyMed Link: | FLUPHENAZINE DECANOATE at DailyMed |
Recent Clinical Trials for FLUPHENAZINE DECANOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Immune Control | Phase 2 |
| Tufts Medical Center | Phase 2 |
| National Institute of Mental Health (NIMH) | Phase 4 |
Pharmacology for FLUPHENAZINE DECANOATE
| Drug Class | Phenothiazine |
Anatomical Therapeutic Chemical (ATC) Classes for FLUPHENAZINE DECANOATE
US Patents and Regulatory Information for FLUPHENAZINE DECANOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 203732-001 | Jul 3, 2014 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Msn | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 215365-001 | Nov 2, 2023 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Gland Pharma Ltd | FLUPHENAZINE DECANOATE | fluphenazine decanoate | INJECTABLE;INJECTION | 215509-001 | Mar 30, 2023 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
